Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1509-1516

  Miller, Barbra S ^a   Ignatoski, Kathleen M ^a   Daignault, Stephanie ^a   Lindland, Ceit ^a   Doherty, Megan ^a   Gauger, Paul G ^a   Hammer, Gary D ^a   Wang, Stewart C ^a   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ARTICLE; BACK; CACHEXIA; CANCER STAGING; FEMALE; HUMAN; INTRAABDOMINAL FAT; KAPLAN MEIER METHOD; MALE; MORTALITY; MUSCLE ATROPHY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PSOAS MUSCLE; RETROSPECTIVE STUDY; SKELETAL MUSCLE; SUBCUTANEOUS FAT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; CACHEXIA; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KAPLAN-MEIER ESTIMATE; LUMBOSACRAL REGION; MALE; MUSCLE, SKELETAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PSOAS MUSCLES; RETROSPECTIVE STUDIES; SARCOPENIA; SUBCUTANEOUS FAT;

EID: 84864286450     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1581-5     Document Type: Article

References (21)

1. Miller BS, Gauger PG, Hammer GD et al (2010) Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg 395: 955-961
2. Bilimoria KY, Shen WT, Elaraj D et al (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113:3130-3136
3. Sabolch A, Feng M, Griffith K et al (2011) Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 80:1477-1484
4. Polat B, Fassnacht M, Pfreundner L et al (2009) Radiotherapy in adrenocortical carcinoma. Cancer 115:2816-2823
5. Steensma DP, Loprinzi CL (2000) The art and science of prognosis in patients with advanced cancer. Eur J Cancer 36: 2025-2027
6. Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. Br Med J 320:469-472 (Pubitemid 30173113)
7. Lang T, Streeper T, Cawthon P et al (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21:543-559
8. Tosteson AN, Gottlieb DJ, Radley DC et al (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463-1472 (Pubitemid 47512685)
9. Longstreth WT Jr, Bernick C, Fitzpatrick A et al (2001) Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 56:368-375 (Pubitemid 32144149)
10. Englesbe MJ, Patel SP, He K et al (2010) Sarcopenia and mortality after liver transplantation. J Am Coll Surg 211:271-278
11. Lee JS, He K, Harbaugh CM et al (2011) Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg 53:912-917
12. Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489-495
13. Lughezzani G, Sun M, Perrotte P et al (2010) The European Network for the Study of Adernal Tumors is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer 46:713-719
14. Miller BS, Ignatoski KM, Daignault S et al (2011) A quantitative tool to objectively assess degree of sarcopenia in patients with hypercortisolism. Surgery 150(6):1178-1185
15. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population- based study. Lancet Oncol 9:629-635
16. Mourtzakis M, Prado CM, Lieffers JR et al (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997-1006
17. Prado CM, Birdsell LA, Baracos VE (2009) The emerging role of CT in assessing cancer cachexia. Curr Opin Support Palliat Care 3:269-275
18. Stephens NA, Skipworth RJ, Macdonald AJ et al (2011) Intramyocellular lipid droplets increase with progression of cachexia in cancer patients. J Cachexia Sarcopenia Muscle 2:111-117
19. Goodpaster BH, Kelley DE, Thaete FL et al (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89:104-110 (Pubitemid 30482569)
20. Prado CM, Baracos VE, McCargar LJ et al (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264-3268 (Pubitemid 46944911)
21. Andreyev HJ, Norman AR, Oates J et al (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503-509 (Pubitemid 28179346)